ALEC
Price
$2.12
Change
-$0.09 (-4.07%)
Updated
Sep 15, 10:51 AM (EDT)
Capitalization
247.88M
56 days until earnings call
Intraday BUY SELL Signals
EDIT
Price
$2.63
Change
-$0.11 (-4.01%)
Updated
Sep 15, 10:59 AM (EDT)
Capitalization
420.81M
55 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

ALEC vs EDIT

ALEC vs EDIT Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
ALEC vs. EDIT commentary
Sep 15, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ALEC is a Hold and EDIT is a Hold.

Interact to see
Advertisement
SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
EDIT($421M) has a higher market cap than ALEC($248M). ALEC YTD gains are higher at: 41.667 vs. EDIT (33.659). EDIT has higher annual earnings (EBITDA): -67.46M vs. ALEC (-117.76M). EDIT has more cash in the bank: 212M vs. ALEC (173M). EDIT has less debt than ALEC: EDIT (15.5M) vs ALEC (32.8M). EDIT has higher revenues than ALEC: EDIT (47M) vs ALEC (13.9M).
ALECEDITALEC / EDIT
Capitalization248M421M59%
EBITDA-117.76M-67.46M175%
Gain YTD41.66733.659124%
P/E RatioN/AN/A-
Revenue13.9M47M30%
Total Cash173M212M82%
Total Debt32.8M15.5M212%
FUNDAMENTALS RATINGS
ALEC vs EDIT: Fundamental Ratings
ALEC
EDIT
OUTLOOK RATING
1..100
8931
VALUATION
overvalued / fair valued / undervalued
1..100
77
Overvalued
34
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
10099
PRICE GROWTH RATING
1..100
4751
P/E GROWTH RATING
1..100
91100
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

EDIT's Valuation (34) in the Biotechnology industry is somewhat better than the same rating for ALEC (77). This means that EDIT’s stock grew somewhat faster than ALEC’s over the last 12 months.

EDIT's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as ALEC (100). This means that EDIT’s stock grew similarly to ALEC’s over the last 12 months.

EDIT's SMR Rating (99) in the Biotechnology industry is in the same range as ALEC (100). This means that EDIT’s stock grew similarly to ALEC’s over the last 12 months.

ALEC's Price Growth Rating (47) in the Biotechnology industry is in the same range as EDIT (51). This means that ALEC’s stock grew similarly to EDIT’s over the last 12 months.

ALEC's P/E Growth Rating (91) in the Biotechnology industry is in the same range as EDIT (100). This means that ALEC’s stock grew similarly to EDIT’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ALECEDIT
RSI
ODDS (%)
Bearish Trend 1 day ago
82%
Bearish Trend 1 day ago
89%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
85%
Bullish Trend 1 day ago
81%
Momentum
ODDS (%)
Bearish Trend 1 day ago
89%
Bearish Trend 1 day ago
90%
MACD
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
90%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
87%
Bearish Trend 1 day ago
90%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
79%
Bearish Trend 1 day ago
90%
Advances
ODDS (%)
Bullish Trend 14 days ago
84%
Bullish Trend 1 day ago
79%
Declines
ODDS (%)
Bearish Trend 6 days ago
87%
Bearish Trend 6 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
85%
Bullish Trend 1 day ago
74%
Aroon
ODDS (%)
Bullish Trend 1 day ago
79%
Bullish Trend 1 day ago
77%
COMPARISON
Comparison
Sep 15, 2026
Stock price -- (ALEC: $2.21 vs. EDIT: $2.74)
Brand notoriety: ALEC and EDIT are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ALEC: 172% vs. EDIT: 81%
Market capitalization -- ALEC: $247.88M vs. EDIT: $420.81M
ALEC [@Biotechnology] is valued at $247.88M. EDIT’s [@Biotechnology] market capitalization is $420.81M. The market cap for tickers in the [@Biotechnology] industry ranges from $58 to $131.68B. The average market capitalization across the [@Biotechnology] industry is $2.24B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ALEC’s FA Score shows that 0 FA rating(s) are green while EDIT’s FA Score has 0 green FA rating(s).

  • ALEC’s FA Score: 0 green, 5 red.
  • EDIT’s FA Score: 0 green, 5 red.
According to our system of comparison, EDIT is a better buy in the long-term than ALEC.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ALEC’s TA Score shows that 4 TA indicator(s) are bullish while EDIT’s TA Score has 4 bullish TA indicator(s).

  • ALEC’s TA Score: 4 bullish, 5 bearish.
  • EDIT’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, ALEC is a better buy in the short-term than EDIT.

Price Growth

ALEC (@Biotechnology) experienced а -10.16% price change this week, while EDIT (@Biotechnology) price change was -15.17% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -5.85%. For the same industry, the average monthly price growth was -3.79%, and the average quarterly price growth was +6.70%.

Reported Earning Dates

ALEC is expected to report earnings on Nov 10, 2026.

EDIT is expected to report earnings on Nov 09, 2026.

Industries' Descriptions

@Biotechnology (-5.85% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

View a ticker or compare two or three
ALEC
Daily Signal:
Gain/Loss:
EDIT
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
LVOAX19.63N/A
N/A
Lord Abbett Value Opportunities A
FIQTX12.18N/A
N/A
Fidelity Advisor Capital & Income Z
MADRX27.15-0.03
-0.11%
Madison Dividend Income R6
QSMNX22.15-0.09
-0.40%
AQR Small Cap Multi-Style N
TRQZX99.08-0.58
-0.58%
T. Rowe Price Mid-Cap Growth Z

ALEC and

Correlation & Price change

A.I.dvisor indicates that over the last year, ALEC has been loosely correlated with ARCT. These tickers have moved in lockstep 62% of the time. This A.I.-generated data suggests there is some statistical probability that if ALEC jumps, then ARCT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ALEC
1D Price
Change %
ALEC100%
+3.27%
ARCT - ALEC
62%
Loosely correlated
+3.80%
EDIT - ALEC
41%
Loosely correlated
+1.48%
CRBU - ALEC
40%
Loosely correlated
+1.57%
VYGR - ALEC
38%
Loosely correlated
N/A
BCYC - ALEC
36%
Loosely correlated
+0.78%
More

EDIT and

Correlation & Price change

A.I.dvisor indicates that over the last year, EDIT has been closely correlated with BEAM. These tickers have moved in lockstep 66% of the time. This A.I.-generated data suggests there is a high statistical probability that if EDIT jumps, then BEAM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To EDIT
1D Price
Change %
EDIT100%
+1.48%
BEAM - EDIT
66%
Closely correlated
+0.54%
CRBU - EDIT
65%
Loosely correlated
+1.57%
PRME - EDIT
64%
Loosely correlated
+1.60%
NTLA - EDIT
60%
Loosely correlated
+1.11%
VYGR - EDIT
59%
Loosely correlated
N/A
More